Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

People

Nature Biotechnology volume 40, page 1880 (2022)Cite this article

Recent moves of note in and around the biotech and pharma industries.

“Martin and Louis are stellar additions to the LifeMine executive team and share in our vision to reinvent small-molecule drug discovery through genomic search and retrieval from the biosphere,” says Gregory Verdine, co-founder, president and CEO of LifeMine. “We continue to make substantial progress scaling our Avatar-Rx platform and advancing our multiple drug discovery programs towards the clinic with unparalleled speed, predictability and scalability. Martin and Louis’s experience and expertise will only help further accelerate our efforts.”

This is a preview of subscription content, access via your institution

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Learn more

Prices may be subject to local taxes which are calculated during checkout

Rights and permissions

Reprints and Permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

People. Nat Biotechnol 40, 1880 (2022). https://doi.org/10.1038/s41587-022-01606-6

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s41587-022-01606-6

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing